Advertisement
Research Article| Volume 7, ISSUE 3, P567-585, September 1987

Download started.

Ok

Newer Cardiae Agents: Antiarrhythmics and Antianginal Agents

  • Michael J. Kelner
    Correspondence
    University of California, San Diego Medical Center, Toxicology Department, 225 Dickinson Street, San Diego, California 92103
    Affiliations
    Assistant Professor of Pathology, University of California, San Diego School of Medicine, La Jolla; Director of Special Chemistry and Associate Director of Toxicology, University of California, San Diego Medical Center, San Diego, California

    Director of Special Chemistry and Associate Director of Toxicology, University of California, San Diego Medical Center, San Diego, California
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30732-7
Newer Cardiae Agents: Antiarrhythmics and Antianginal Agents
Previous ArticleMonitoring Cyclic Antidepressants
Next ArticleCardiac Glycosides
      This paper is only available as a PDF. To read, Please Download here.
      The following cardiac agents are reviewed: amiodarone, flecainide, mexiletine, tocainide, verapamil, nifedipine, and diltiazem. Each of the agents is discussed with regard to chemical structure, clinical use, pharmacokinetics, adverse effects, drug interactions, and methods for monitoring therapeutic concentrations.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Abernathy D.R.
        • Todd E.L.
        • Mitchell J.
        Verapamil and norverapamil determination in human plasma by gas-liquid chromatography using nitrogen-phosphorus detection.
        Pharmacology. 1984; 29: 264-268
        • Anastasiou-Nana M.
        • Levis G.M.
        • Moulopoulos S.
        Pharmacokinetics of amiodarone after intravenous and oral administration.
        Int J Clin Pharmacol Ther Toxicol. 1982; 20: 524-529
        • Anastassiades C.J.
        Nifedipine and beta-blocker drugs.
        Br Med J. 1980; 281: 1251-1252
        • Andersen H.J.
        Excretion of verapamil in human milk.
        Eur J Clin Pharmacol. 1983; 25: 279-280
        • Anderson J.L.
        • Stewart J.R.
        • Perry B.A.
        • et al.
        Oral flecainide acetate for the treatment of ventricular arrhythmias.
        N Engl J Med. 1981; 305: 473-477
        • Andersson D.E.H.
        • Rojdmark S.
        Improvement of glucose tolerance by verapamil in patients with non-insulin-dependent diabetes mellitus.
        Acta Med Scand. 1981; 210: 27-33
        • Andreasen F.
        • Agerbaek H.
        • Bjerregaard P.
        • et al.
        Pharmacokinetics of amiodarone after intravenous and oral administration.
        Eur J Clin Pharmacol. 1981; 19: 293-299
        • Antonsson A.M.
        • Gyllenhaal O.
        • Kylberg-Hanssen K.
        • et al.
        Monitoring of S- and R-tocainide in human plasma after heptafluorobutylation, separation on Chirasil-Val and electron-capture detection.
        J Chromatogr. 1984; 308: 181-187
        • Bach P.R.
        Determination of nifedipine in serum or plasma by reversed-phase liquid chromatography.
        Clin Chem. 1983; 29: 1344-1348
        • Becket A.H.
        • Chidomere E.C.
        The identification and analysis of mexiletine and its metabolic products in man.
        J Pharm Pharmacol. 1977; 29: 281-285
        • Begg E.J.
        • Chinwah P.M.
        • Webb C.
        • et al.
        Enhanced metabolism of mexiletine after phenytoin administration.
        Br J Clin Pharmacol. 1982; 14: 219-223
        • Belz G.G.
        • Aust P.E.
        • Munkes R.
        Digoxin plasma concentrations and nifedipine.
        Lancet. 1981; 1: 844-845
        • Bradbrook I.D.
        • James C.
        • Rogers H.J.
        A rapid method for the determination of plasma mexiletine levels by gas-chromatography.
        Br J Clin Pharmacol. 1977; 4: 380-382
        • Brown J.E.
        • Shand D.G.
        Therapeutic drug monitoring of antiarrhythmic agents.
        Clin Pharmacokinet. 1982; 7: 125-148
        • Byrnes E.W.
        • McMaster P.D.
        • Smith E.R.
        • et al.
        New antiarrhythmic agents. 1. Primary alpha-amino anilides.
        J Med Chem. 1979; 22: 1171-1176
        • Campbell N.P.S.
        • Pantridge J.F.
        • Adgey A.A.J.
        Mexiletine in the management of ventricular dysrhythmias.
        Eur J Cardiol. 1977; 6: 245-258
        • Campbell N.P.S.
        • Kelley J.G.
        • Adgey A.A.J.
        • et al.
        The clinical pharmacology of mexiletine.
        Br J Clin Pharmacol. 1978; 6: 103-108
        • Chang S.F.
        • Welscher T.M.
        • Miller A.M.
        • et al.
        High-performance liquid chromatographic method for the quantitation of flecainide, a new antiarrhythmic, in human plasma and urine.
        J Chromatogr. 1983; 272: 341-350
        • Chang S.F.
        • Miller A.M.
        • Jernberg M.J.
        • et al.
        Measurement of flecainide acetate in human plasma by an extraction spectrofluorometric method.
        Arzneim Forsch Drug Res. 1983; 33: 251-255
        • Chang S.F.
        • Miller A.M.
        • Fox J.M.
        • et al.
        Application of a bonded phase extraction column for the rapid sample preparation of flecainide from human plasma for high-performance liquid chromatographic analysis—fluorescence or ultraviolet detection.
        Ther Drug Monit. 1984; 6: 105-111
        • Chang S.F.
        • Miller A.M.
        • Fox J.M.
        • Welscher T.M.
        Determination of flecainide in human plasma by high performance liquid chromatography with fluorescence detection.
        J Liq Chromatogr. 1984; 7: 167-176
        • Clozel J.P.
        • Caille G.
        • Taeymans Y.
        • et al.
        Improved gas chromatographic determination of diltiazem and deacetyldiltiazem in human plasma.
        J Pharm Sci. 1984; 73: 207-209
        • Cole S.C.J.
        • Flanagan R.J.
        Rapid high-performance liquid chromatographic method for the measurement of verapamil and norverapamil in blood plasma or serum.
        J Chromatogr. 1981; 218: 621-629
        • Conrad G.J.
        • Ober R.E.
        Metabolism of flecainide.
        Am J Cardiol. 1984; 53: 41B-51B
        • Currie P.
        • Ramsdale D.R.
        Paranoid psychosis induced by tocainamide.
        Br Med J. 1984; 288: 606-607
        • Day T.
        • Hunt D.
        Interaction between mexiletine and digoxin.
        Med J Austr. 1983; 2: 630
        • Debbas N.M.G.
        • duCailar C.
        • Sassine A.
        • et al.
        Determination of cardiac and plasma drug levels during long-term amiodarone therapy.
        Eur J Clin Invest. 1983; 13: 123-127
        • dejong J.W.
        • Hegge J.A.J.
        • Harmsen E.
        • et al.
        Fluorometric liquid chromatographic assay for the antiarrhythmic agent flecainide in blood plasma.
        J Chromatogr. 1982; 229: 498-502
        • Dokladalova J.
        • Tykal J.A.
        • Coco S.J.
        • et al.
        Occurrence and measurement of nifedipine and its nitropyridine derivative in human blood plasma.
        J Chromatogr. 1982; 231: 451-458
        • Duff H.J.
        • Roden D.M.
        • Primm R.K.
        • et al.
        Mexiletine in the treatment of resistant ventricular arrhythmias: Enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.
        Circulation. 1983; 67: 1124-1128
        • Duff H.J.
        • Roden D.M.
        • Marney S.
        • et al.
        Molecular basis for the antigenicity of lidocaine analogs: Tocainide and mexiletine.
        Am Heart J. 1984; 107: 585-589
        • Dusci L.J.
        • Hackett L.P.
        Simultaneous determination of lidocaine, mexiletine, diisopyramide, and quinidine in plasma by high performance liquid chromatography.
        J Anal Toxicol. 1985; 9: 67-70
        • Eichelbaum M.
        • Ende M.
        • Remberg G.
        • et al.
        The metabolism of DL-14C-verapamil in man.
        Drug Metab Dispos. 1978; 7: 145-148
        • Elfving S.M.
        • Svens E.H.
        • Leskinen E.E.A.
        Gas-liquid chromatographic determination of mexiletine in human serum with nitrogen-sensitive detector.
        J Clin Chem Biochem. 1981; 19: 1189-1191
        • Elkayam U.
        • Parikh K.
        • Torkan B.
        • et al.
        Effect of diltiazem on renal clearance and serum concentration of digoxin in patients with cardiac disease.
        Am J Cardiol. 1985; 55: 1393-1395
        • Elvin A.T.
        • Keenaghan J.B.
        • Byrnes E.W.
        Tocainide conjugation in humans: Novel biotransformation pathway for a primary amine.
        J Pharm Sci. 1980; 69: 47-49
        • Flanagan R.J.
        • Storey G.C.A.
        • Holt D.W.
        • et al.
        Identification and measurement of desthy-lamiodarone in blood plasma specimens from amiodarone-treated patients.
        J Pharm Pharmacol. 1982; 34: 638-643
        • Foster T.S.
        • Hamann S.R.
        • Richards V.R.
        • et al.
        Nifedipine kinetics and bioavailability after single intravenous and oral doses in normal subjects.
        J Clin Pharmacol. 1983; 23: 161-170
        • Gal J.
        • French T.A.
        • Zysset T.
        • et al.
        Disposition of (R,S)-tocainide.
        Drug Metab Dispos. 1982; 10: 399-404
        • Gettings S.D.
        • Flanagan R.J.
        • Holt D.W.
        Simple method for the measurement of tocainide and lignocaine in blood plasma or serum using gas-liquid chromatography with flame ionization detector.
        J Chromatogr. 1981; 225: 469-475
        • Giugliano D.
        • Torella R.
        • Cacciapuoti F.
        • et al.
        Impairment of insulin secretion in man by nifedipine.
        Eur J Clin Pharmacol. 1980; 18: 395
        • Gore J.M.
        • Haffajee C.I.
        • Alpert J.S.
        Interaction of aminodarone and diphenylhydantoin.
        Am J Cardiol. 1984; 54: 1145
        • Graffner C.
        • Conradson T.B.
        • Hofvendahl S.
        • et al.
        Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction.
        Clin Pharmacol Ther. 1980; 27: 64-71
        • Grech-Belanger O.
        Gas chromatographic method for the routine serum monitoring of mexiletine.
        J Chromatogr. 1984; 309: 165-169
        • Grech-Belanger O.
        • Turgeon J.
        • Gilbert M.
        High-pressure liquid chromatographic assay for mexiletine in serum.
        J Chromatogr Sci. 1984; 22: 490-492
        • Grech-Belanger O.
        • Gilbert M.
        • Turgeon J.
        • et al.
        Effect of cigarette smoking on mexiletine kinetics.
        Clin Pharmacol Ther. 1985; 37: 638-643
        • Grech-Belanger O.
        • Turgeon J.
        • Gilbert M.
        High-performance liquid chromatographic assay for mexiletine enantiomers in human plasma.
        J Chromatogr. 1985; 337: 172-177
        • Guehler J.
        • Gornick C.C.
        • Tobler G.
        • et al.
        Electrophysiologic properties of flecainide acetate and its major metabolites in the canine heart.
        Am J Cardiol. 1985; 55: 807-812
        • Gurley B.J.
        • Buice R.G.
        • Sidhu P.
        Reversed-phase high performance liquid chromatographic determination of nifedipine in human plasma.
        Ther Drug Monit. 1985; 7: 321-323
        • Haffajee C.l.
        • Love L.C.
        • Canada A.T.
        • et al.
        Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
        Circulation. 1983; 67: 1347-1355
        • Hamann S.R.
        • McAllister Jr, R.G.
        Measurement of nifedipine plasma by gas-liquid chromatography and electron-capture.
        Clin Chem. 1983; 29: 158-160
        • Hamer A.
        • Peter T.
        • Mandel W.J.
        • et al.
        The potentiation of warfarin anticoagulation by amiodarone.
        Circulation. 1982; 65: 1025-1029
        • Harapat S.R.
        • Kates R.E.
        Rapid high-pressure liquid chromatographic analysis of verapamil in blood and plasma.
        J Chromatogr. 1979; 170: 385-390
        • Harrison D.J.
        • Wathen C.G.
        Paranoid psychosis induced by tocainide.
        Br Med J. 1984; 288: 1010-1011
        • Hawthrone G.C.
        • Campbell N.P.S.
        • Geddes J.S.
        • et al.
        Amiodarone-induced hypothyroidism.
        Arch Intern Med. 1985; 145: 1016-1019
        • Hege H.G.
        Gas chromatographic determination of verapamil in plasma and urine.
        Arzeneim Forsch Drug Res. 1979; 29: 1681-1684
        • Heger J.J.
        • Prystowsky E.N.
        • Zipes D.P.
        Relationship between amiodarone dosage, drug concentrations and adverse side effects.
        Am Heart J. 1983; 106: 931-935
        • Holt D.W.
        • Flanagan R.J.
        • Hayler A.M.
        • et al.
        Simple gas-liquid chromatographic method for the measuring of mexiletine and lignocaine in blood-plasma or serum.
        J Chromatogr. 1979; 169: 295-301
        • Holt D.W.
        • Tucker G.T.
        • Jackson P.R.
        • et al.
        Amiodarone pharmacokinetics.
        Am Heart J. 1983; 106: 840-846
        • Horn H.R.
        • Hadidian Z.
        • Johnson J.L.
        • et al.
        Safety evaluation of tocainide in the American Emergency Use Program.
        Am Heart J. 1980; 100: 1037-1040
        • Ikeda N.
        • Singh B.N.
        • Davis L.D.
        • et al.
        Effects of flecainide on the electrophysiologic properties of isolated canine and rabbit myocardial fibers.
        J Am Coll Cardiol. 1985; 5: 303-310
        • Ikram H.
        Hemodynamic and electrophysiologic interactions between antiarrhythmic drugs and beta blockers, with special reference to tocainide.
        Am Heart J. 1980; 100: 1076-1080
        • Ingram D.V.
        Ocular effects in long-term amiodarone therapy.
        Am Heart J. 1983; 106: 902-905
        • Inoue H.
        • Unno N.
        Excretion of verapamil in human milk.
        Br Med J. 1983; 287: 1596
        • Ishikawa T.
        • Imamura T.
        • Koiwaya Y.
        • et al.
        Atrioventricular dissociation and sinus arrest by oral diltiazem.
        N Engl J Med. 1983; 305: 1124
        • Jakobsen P.
        • Pedersoen O.L.
        • Mikkelsen E.
        Gas chromatographic determination of nifedipine and one of its metabolites using electron capture detection.
        J Chromatogr. 1979; 162: 81-87
        • Jaouni T.M.
        • Leon M.B.
        • Rosing D.R.
        • et al.
        Analysis of verapamil in plasma by liquid chromatography.
        J Chromatogr. 1980; 182: 473-477
        • Johansson L.
        • Vessman J.
        Determination of tocainide in human plasma by gas chromatography with nitrogen-selective detection after Schiff base formation.
        J Chromatogr. 1982; 239: 323-324
        • Johnson J.D.
        • Carlson G.L.
        • Fox J.M.
        • et al.
        Quantitation of flecainide acetate, a new antiarrhythmic agent, in biological fluids by gas chromatography with electron-capture detectiion.
        J Pharm Sci. 1984; 73: 1469-1471
        • Johnston A.
        • Burgess C.D.
        • Warrington S.J.
        • et al.
        The effect of spontaneous changes in urinary pH on mexiletine plasma concentrations and excretion during chronic administration to healthy volunteers.
        Br J Clin Pharmacol. 1979; 8: 349-352
        • Kacprowizc A.T.
        Improved gas-liquid chromatographic method for measurement of mexiletine in plasma.
        Clin Chem. 1982; 28: 245-246
        • Kacprowizc A.T.
        • Fullinaw R.O.
        • Bury R.W.
        High-performance liquid chromatographic measurement of verapamil in plasma using a diol column.
        J Chromatogr. 1985; 337: 412-415
        • Kannan R.
        • Nademanee K.
        • Hendrickson J.
        • et al.
        Amiodarone kinetics after oral doses.
        Clin Pharmacol Ther. 1982; 31: 438-444
        • Kapur P.A.
        • Law T.
        • Watson E.
        Simultaneous quantitation of verapamil, norverapamil, and N-dealkylated metabolites in human plasma following oral administration.
        J Chromatogr. 1985; 337: 160-165
        • Kates R.E.
        • Keefe D.L.D.
        • Schwartz J.
        • et al.
        Verapamil disposition kinetics in chronic atrial fibrillation.
        Clin Pharmacol Ther. 1981; 30: 44-51
        • Kelly J.G.
        Measurement of mexiletine concentrations.
        Postgrad Med J. 1977; 53: 48-49
        • Kelly J.G.
        • Nimmo J.
        • Rae R.G.
        • et al.
        Spectrofluorometric and gas-liquid chromatographic methods for the estimation of mexiletine (Kö1173) in plasma and urine.
        J Pharm Pharmacol. 1973; 25: 550-553
        • Kelly R.
        • Christmore D.
        • Smith R.
        • et al.
        Mexiletine in plasma by high pressure liquid chromatography.
        Ther Drug Monit. 1981; 3: 279-286
        • Kiddie M.A.
        • Kaye C.M.
        • Turner P.
        • et al.
        The influence of urinary pH on the elimination of mexiletine.
        Br J Clin Pharmacol. 1974; 1: 229
        • Klein H.O.
        • Lang R.
        • Weiss E.
        • et al.
        The influence of verpamamil on serum digoxin concentration.
        Circulation. 1982; 65: 998-1003
        • Klein M.D.
        • Levine R.A.
        • Ryan T.J.
        Antiarrhythmic efficacy, pharmacokinetics and clinical safety of tocainide in convalescent myocardial infarction patients.
        Chest. 1980; 77: 726-730
        • Kleinbosesem C.H.
        • van Brummelen P.
        • Sandberg T.E.H.
        • et al.
        Nifedipine: Kinetics and dynamics in healthy subjects.
        Clin Pharmacol Ther. 1984; 35: 742-749
        • Koike Y.
        • Shimamura K.
        • Shudo I.
        • et al.
        Pharmacokinetics of verapamil in man.
        Rec Commun Chem Pathol Pharmacol. 1979; 24: 37-47
        • Kuwada M.
        • Tateyama T.
        • Tsutsumi J.
        Simultaneous determination of verapamil and its 7 metabolites by high-performance liquid chromatography.
        J Chromatogr. 1981; 222: 507-511
        • Lagerstrom P.O.
        • Persson B.A.
        Liquid chromatography in the monitoring of plasma levels of antiarrhythmic drugs.
        J Chromatogr. 1978; 149: 331-340
        • Laika D.
        • Meyer M.B.
        • Duce B.R.
        • et al.
        Kinetics of the oral antiarrhythmic lidocaine congener, tocainide.
        Clin Pharmacol Ther. 1976; 19: 757-766
        • Leroy P.
        • Nicolas A.
        Determination of secondary amino drugs as their metal dithiocarbamate complexes by reversed-phase high-performance liquid chromatography with electrochemical detection.
        J Chromatogr. 1984; 317: 513-521
        • LeWinter M.M.
        • Engler R.L.
        • Karliner J.S.
        Tocainide therapy for treatment of ventricular arrhythmias: Assessment with ambulatory electrocardiographic monitoring and treadmill exercise.
        Am J Cardiol. 1980; 45: 1045-1052
        • Macphee G.I.A.
        • Mclnnes G.T.
        • Thompson G.G.
        • Brodie M.J.
        Verapamil potentiates carbamazepine neurotoxicity.
        Lancet. 1986; 8483: 700-703
        • Maisel A.S.
        • Harvey T.M.
        • Insel P.A.
        Hypotension after quinidine plus verapamil.
        N Engl I Med. 1985; 312: 167-170
        • Marchlinski F.E.
        • Gansler T.S.
        • Waxman H.L.
        • et al.
        Amiodarone pulmonary toxicity.
        Ann Intern Med. 1982; 97: 839-845
        • Marcus F.I.
        Drug interactions with amiodarone.
        Am Heart J. 1983; 106: 924-929
        • Mastropaolo W.
        • Holmes D.R.
        • Osborn M.J.
        • et al.
        Improved liquid-chromatographic determination of mexiletine, an antiarrhythmic drug, in plasma.
        Clin Chem. 1984; 30: 319-322
        • McAllister R.G.
        • Howel S.M.
        Flourometric assay of verapamil in biological fluids and tissues.
        J Pharm Sci. 1976; 65: 431-432
        • McDevitt D.G.
        • Nies A.S.
        • Wilkinson G.R.
        • et al.
        Antiarrhythmic effects of a lidocaine congener, tocainide, 2-amino-2’,6’-propiooxylide, in man.
        Clin Pharmacol Ther. 1976; 19: 396-402
        • McKenna W.J.
        • Harris L.
        • Rowland E.
        • et al.
        Amiodarone therapy during pregnancy.
        Am J Cardiol. 1983; 51: 1231-1233
        • McQuinn R.L.
        • Quarfoth G.J.
        • Johnson J.D.
        • et al.
        Biotransformation and elimination of 14C-flecainide acetate in humans.
        Drug Metab Dispos. 1984; 12: 414-420
        • Meffin P.J.
        • Harapet S.R.
        • Harrison D.C.
        High-pressure liquid chromatographic analysis of drugs in biological fluids. II: Determination of an antiarrhythmic drug, tocainide, as its dansyl derivative using a fluorescence detector.
        J Pharm Sci. 1977; 66: 583-586
        • Meffin P.J.
        • Winkle R.A.
        • Blaschke T.F.
        • et al.
        Response optimization of drug dosage: Antiarrhythmic studies with tocainide.
        Clin Pharmacol Ther. 1977; 22: 42-57
        • Mitchell B.G.
        • Clements J.A.
        • Pottage A.
        • et al.
        Mexiletine disposition.
        Br J Clin Pharmacol. 1983; 16: 281-284
        • Morganroth J.
        • Horowitz L.N.
        Flecainide: Its proarrhythmic effect and expected changes in the surface electrocardiogram.
        Am J Cardiol. 1984; 53: 89B-94B
        • Moysey J.O.
        • Jaggarao N.S.V.
        • Grundy E.N.
        • et al.
        Amiodarone increases plasma digoxin concentrations.
        Br Med J. 1981; 282: 272
        • Muhidden K.A.
        • Johnston A.
        • Turner P.
        The influence of urinary pH on flecainide excretion and its serum pharmacokinetics.
        Br J Clin Pharmacol. 1984; 17: 447-451
        • Nademanee K.
        • Hendrickson J.
        • Kannan R.
        • et al.
        Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias.
        Am Heart J. 1982; 103: 950-959
        • Nakashima T.
        • Inoki M.
        • Nakanishi Y.
        Nifedipine serum concentration.
        Eur J Drug Metab Pharmacol. 1984; 9: 73-78
        • Nauta I.L.
        • Ruland C.M.
        • Hertzberger D.H.
        • et al.
        Heart failure and hepatitis in a patient taking tocainide.
        Int J Cardiol. 1984; 1: 89-90
        • Neugebauer G.
        Comparative cardiovascular actions of verapamil and its major metabolites in the anesthetized dog.
        Cardiovasc Res. 1978; 12: 247-254
        • Okado M.
        • Inque H.
        • Nakamura Y.
        • et al.
        Excretion of diltiazem in human milk.
        N Engl J Med. 1985; 312: 992-993
        • Opie L.H.
        • White D.A.
        Adverse interaction between nifedipine and beta-blockade.
        Br Med J. 1980; 281: 1462
        • Page R.L.
        • Frame L.H.
        • Hoffman B.F.
        • et al.
        Flecainide: Unusual use dependent kinetics (abstract).
        J Am Coll Cardiol. 1984; 3: 616
        • Pederson K.E.
        • Dorph-Pederson A.
        • Hvidt S.
        • et al.
        Effects of nifedipine on digoxin kinetics in healthy patients.
        Clin Pharmacol Ther. 1982; 32: 562-565
        • Pentikainen P.J.
        • Koivula I.H.
        • Hiltunen H.A.
        Effect of rifampin treatment on the kinetics of mexiletine.
        Eur J Clin Pharmacol. 1982; 23: 261
        • Perchalski R.J.
        • Widler B.J.
        • Hammer R.H.
        Flame-ionization and electron-capture GLC determination for the determination of 1-(2,6-dimethylphenoxy)-2’-aminopropane in plasma.
        J Pharm Sci. 1976; 63: 1489
        • Petterson C.
        • Schill G.
        Separation of enantiomeric amines by ion-pair chromatography.
        J Chromatogr. 1981; 204: 179-183
        • Pietta P.
        • Rava A.
        • Biondi P.
        High performance liquid chromatography of nifedipine, its metabolites and photochemical degradation products.
        J Chromatogr. 1981; 210: 516-521
        • Pillai G.K.
        • Axelson J.E.
        • McErlane K.M.
        Electron-capture gas-liquid chromatographic determination of tocainide in biological fluids using fused silica capillary columns.
        J Chromatogr. 1982; 229: 103
        • Pilling M.A.
        • Tse J.
        • Chan K.
        A modified gas-liquid chromatographic assay to monitor plasma mexiletine in a tinnitus study.
        Methods Find Exp Clin Pharmacol. 1982; 4: 243-247

      118. Pirkle WH, Finn J: In Morrison JD (ed): Asymmetric Synthesis. Volume 1. 1983, p 87

        • Plomp T.A.
        • Boom H.T.
        • Maes R.A.
        Measurement of flecainide plasma concentrations by high performance liquid chromatography with fluorescence detection.
        J Anal Toxicol. 1986; 10: 102-106
        • Podrid P.J.
        • Lown B.
        Tocainide for refractory symptomatic ventricular arrhythmias.
        Am J Cardiol. 1982; 49: 1279-1286
        • Pollack P.T.
        • Carruthers S.G.
        • Freeman D.J.
        Simplified liquid-chromatographic assay for amiodarone and desethylamiodarone after solid-phase extraction.
        Clin Chem. 1986; 32: 890-893
        • Prescott L.F.
        • Clements J.A.
        • Pottage A.
        Absorption, distribution and elimination of mexiletine.
        Postgrad Med J. 1977; 53: 50
        • Proelss H.F.
        • Townsend T.B.
        Simultaneous liquid-chromatographic determination of five antiarrhythmic drugs and their major active metabolites in serum.
        Clin Chem. 1986; 32: 1311-1317
        • Raemsch K.D.
        • Sommer J.
        Pharmacokinetics and metabolism of nifedipine.
        Hypertension. 1983; 5: 1118-1124
        • Reece P.A.
        • Stanley P.E.
        High-performance liquid chromatographic assay for tocainide in human plasma.
        J Chromatogr. 1980; 183: 109-114
        • Remberg G.
        • Ende M.
        • Eichelbaum M.
        • et al.
        Mass spectrometric identification of DL-verapamil metabolites.
        Arzneim Forsch Drug Res. 1980; 30: 398-401
        • Riva E.
        • Gerna M.
        • Latina R.
        • et al.
        Pharmacokinetics of amiodarone in man.
        J Cardiovasc Pharm. 1982; 4: 264-269
        • Roden D.M.
        • Reele S.B.
        • Higgens S.B.
        • et al.
        Tocainide therapy for refractory ventricular arrhythmias.
        Am Heart J. 1980; 100: 15-22
        • Ronfeld R.A.
        • Wolshin E.M.
        • Block A.J.
        Tocainide and metabolites. Human pharmacokinetics and animal pharmacology (abstract).
        Clin Pharmacol Ther. 1980; 27: 282
        • Ronfeld R.A.
        • Wolshin E.M.
        • Block A.J.
        On the kinetics and dynamics of tocainide and its metabolites.
        Clin Pharmacol Ther. 1982; 31: 384
        • Rosenbaum M.B.
        • Chiale P.A.
        • Halpern M.S.
        • et al.
        Clinical efficacy of aminodarone as an antiarrhythmic agent.
        Am J Cardiol. 1976; 38: 934-944
        • Rossel M.T.
        • Bogaert M.G.
        Determination of nifedipine in human plasma by capillary gas chromatography with nitrogen detection.
        J Chromatogr. 1983; 279: 675-680
        • Rovei V.
        • Gomeni R.
        • Mitchard M.
        • et al.
        Pharmacokinetics and metabolism of diltiazem in man.
        Acta Cardiol. 1980; 35: 35-45
        • Rovei V.
        • Mitchard M.
        • Morselli P.L.
        Simple, sensitive, and specific gas-chromatographic method for the quantification of diltiazem in human body fluids.
        J Chromatogr. 1977; 138: 391-398
        • Saal A.K.
        • Werner J.A.
        • Gross B.W.
        • et al.
        Interaction of aminodarone with quinidine and procainamide.
        Circulation. 1982; 66: 224
        • Salerno D.M.
        • Granrud G.
        • Sharkey P.
        • et al.
        Pharmacodynamics and side effects of flecainide acetate.
        Clin Pharmacol Ther. 1986; 40: 101-107
        • Sanmarti A.
        • Permanyer-Miraldi G.
        • Castellanos J.M.
        • et al.
        Chronic administration of amiodarone and thyroid function: A follow-up study.
        Am Heart J. 1984; 108: 1262-1268
        • Saunders F.
        • Shedden P.
        Diltiazem.
        Surg Neurol. 1986; 25: 82-84
        • Schlossman K.
        Fluorometrische bestimmung des 4-(2’-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsauredimethylester und seine hauptmetaboliten.
        Arzneim Forsch Drug Res. 1972; 22: 60-62
        • Schomerus M.
        • Spiegelholder B.
        • Stieren B.
        • et al.
        Physiological disposition of verapamil in man.
        Cardiovasc Res. 1976; 10: 605-612
        • Schwarts J.B.
        • Keefe D.L.
        • Kates R.E.
        • et al.
        Verapamil and digoxin.
        Clin Res. 1981; 29: 501A
        • Schwartz J.B.
        • Raizner A.
        • Akers S.
        The effect of nifedipine on serum digoxin concentrations in patients.
        Am Heart J. 1984; 107: 669-673
        • Sedman A.J.
        • Gal J.
        Pre-column derivitization with fluorescamine and high-performance liquid-chromatographic analysis of drugs. Application to tocainide.
        J Chromatogr. 1982; 232: 315-326
        • Shea P.
        • Lai R.
        • Kim S.S.
        • et al.
        Flecainide and amiodarone interaction.
        J Am Coll Cardiol. 1986; 7: 1127-1130
        • Shipe J.R.
        Liquid-chromatographic determination of amiodarone and its desethyl metabolite in plasma.
        Clin Chem. 1984; 30: 1259
        • Singh B.N.
        • Ellrodt G.
        • Peter C.T.
        Verapamil: A review of its pharmacologic properties and therapeutic use.
        Drugs. 1978; 15: 169-197
        • Smith K.J.
        • Meffin P.J.
        Mexiletine analysis in blood and plasma using gas chromatography and nitrogen-selective detector.
        J Chromatogr. 1980; 181: 469-472
        • Smith M.S.
        • Verghese C.P.
        • Shand D.G.
        • et al.
        Pharmacokinetic and pharmacodynamic effects of diltiazem.
        Am J Cardiol. 1983; 51: 1369-1374
        • Smith R.
        • Schwartz A.S.
        Diltiazem prophylaxis in refractory migraine.
        N Engl J Med. 1984; 310: 1327-1328
        • Sonnhag C.
        Efficacy and tolerance of tocainide during acute and long-term treatment of chronic ventricular dysrhythmias.
        Eur J Clin Pharmacol. 1980; 18: 301-310
        • Spiegelhalder B.
        • Eichelbaum M.
        Determination of verapamil in human plasma by mass-fragmentation using stable isotope-labelled verapamil as internal standard.
        Arzneimittelforschnung Drug Res. 1977; 27: 94-97
        • Staubli M.
        • Bicher J.
        • Galeazzi R.L.
        • et al.
        Serum concentrations of amiodarone during long-term therapy.
        Eur J Clin Pharmacol. 1983; 24: 485-494
        • Storey G.C.A.
        • Holt D.W.
        • Holt P.
        • et al.
        High-performance liquid chromatographic measurement of amiodarone and its desethyl metabolite.
        Ther Drug Monit. 1982; 4: 385-388
        • Sugihara J.
        • Sugawara Y.
        • Ando H.
        • et al.
        Studies on the metabolism of diltiazem in man.
        J Pharmacobiodynamics. 1984; 7: 24-32
        • Talbot R.G.
        • Julian D.G.
        • Prescott L.F.
        Long-term treatment of ventricular arrhythmias with oral mexiletine.
        Am Heart J. 1976; 91: 58-65
        • Tartini R.
        • Kappenberger L.
        • Steinbrunn W.
        • et al.
        Dangerous interaction between amiodarone and quinidine.
        Lancet. 1982; 1: 1327-1329
        • Thomson A.H.
        • Murdoch G.
        • Pottage A.
        • et al.
        The pharmacokinetics of R and S-tocainide in patients with acute ventricular arrhythmias.
        Br J Clin Pharmacol. 1986; 21: 149-154
        • Tjandra Maga T.B.
        • Verbesselt R.
        • Van Hecken A.
        Oral flecainide elimination kinetics: Effects of cimetidine (abstract).
        Circulation. 1983; 68: 416
        • Todd G.
        • Bourne D.
        • McAllister Jr, R.G.
        Measurement of verapamil concentration in plasma by gas chromatography and high pressure liquid chromatography.
        Ther Drug Monit. 1980; 2: 411-416
        • Vailiades J.
        • Wilkerson K.
        • Ellul D.
        • et al.
        Gas-chromatographic determination of verapamil and norverapamil with nitrogen-selective detector.
        Clin Chem. 1982; 28: 638-641
        • Venkataramanan R.
        • Axelson J.E.
        Electron-capture detector GLC technique for estimating tocainide in biological fluids.
        J Pharm Sci. 1978; 67: 201-205
        • Volosin K.
        • Greenberg R.M.
        • Greenspon A.J.
        Tocainide associated agranulocytosis.
        Am Heart J. 1985; 109: 1392-1393
        • Watson E.
        • Kapur P.A.
        High-pressure liquid chromatographic determination of verapamil in plasma by fluorescence detection.
        J Pharm Sci. 1981; 70: 800-801
        • Weeks C.E.
        • Conrad G.J.
        • Kvam D.C.
        • et al.
        The effect of flecainide acetate, a new antiarrhythmic, on plasma digoxin levels.
        J Clin Pharmacol. 1986; 26: 27-31
        • Weir S.J.
        • Ueda C.T.
        Rapid liquid chromatographic assay for the determination of amiodarone and its N-deethyl metabolite in plasma, urine, and bile.
        J Pharm Sci. 1985; 74: 460-465
        • Wiegers U.
        • Hanrath P.
        • Kuck K.H.
        • et al.
        Pharmacokinetics of tocainide in patients with renal dysfunction and during hemodialysis.
        Eur J Clin Pharmacol. 1983; 24: 503-507
        • Wiens R.E.
        • Runser D.J.
        • Lacz J.P.
        • et al.
        Quantitation of diltiazem and desacetyldiltiazem in dog plasma by high-performance liquid chromatography.
        J Pharm Sci. 1984; 73: 688-689
        • Winkle R.A.
        • Meffin P.J.
        • Fitzgerald J.W.
        • et al.
        Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide.
        Circulation. 1976; 54: 884-889
        • Winkle R.A.
        • Mason J.W.
        • Harrison D.C.
        • et al.
        Tocainide for drug-resistant ventricular arrhythmias: efficacy, side effects, and lidocaine responsiveness for predicting tocainide efficacy.
        Am Heart J. 1980; 100: 1031-1036
        • Wolshin E.M.
        • Cavanaugh M.H.
        • Marion C.V.
        • et al.
        Assay of tocainide in blood by high-pressure liquid chromatography.
        J Pharm Sci. 1978; 67: 1692-1695
        • Woodcock B.G.
        • Rietbrock I.
        • Vohringer H.F.
        • et al.
        Verapamil disposition in liver disease and intensive care patients.
        Clin Pharmacol Ther. 1981; 26: 27-34
        • Zipes D.P.
        • Troup P.J.
        New antiarrhythmic agents.
        Am J Cardiol. 1978; 41: 1005-1024
        • Zsoter T.T.
        • Church J.G.
        Pharmacodynamics of calcium antagonists.
        Drugs. 1983; 25: 93-112

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30732-7

      Copyright

      © 1987 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX